These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 22226054)
1. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes. Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054 [TBL] [Abstract][Full Text] [Related]
3. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Novosyadlyy R; Lann DE; Vijayakumar A; Rowzee A; Lazzarino DA; Fierz Y; Carboni JM; Gottardis MM; Pennisi PA; Molinolo AA; Kurshan N; Mejia W; Santopietro S; Yakar S; Wood TL; LeRoith D Cancer Res; 2010 Jan; 70(2):741-51. PubMed ID: 20068149 [TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. Ferguson RD; Gallagher EJ; Cohen D; Tobin-Hess A; Alikhani N; Novosyadlyy R; Haddad N; Yakar S; LeRoith D Endocr Relat Cancer; 2013 Jun; 20(3):391-401. PubMed ID: 23572162 [TBL] [Abstract][Full Text] [Related]
5. EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice. Zelenko Z; Gallagher EJ; Antoniou IM; Sachdev D; Nayak A; Yee D; LeRoith D Endocr Relat Cancer; 2016 Sep; 23(9):747-58. PubMed ID: 27435064 [TBL] [Abstract][Full Text] [Related]
6. Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia. Gallagher EJ; Fierz Y; Vijayakumar A; Haddad N; Yakar S; LeRoith D Oncogene; 2012 Jul; 31(27):3213-22. PubMed ID: 22037215 [TBL] [Abstract][Full Text] [Related]
7. Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression. Zelenko Z; Gallagher EJ; Tobin-Hess A; Belardi V; Rostoker R; Blank J; Dina Y; LeRoith D Oncogene; 2017 Mar; 36(10):1394-1403. PubMed ID: 27568979 [TBL] [Abstract][Full Text] [Related]
8. Investigating new therapeutic strategies targeting hyperinsulinemia's mitogenic effects in a female mouse breast cancer model. Rostoker R; Bitton-Worms K; Caspi A; Shen-Orr Z; LeRoith D Endocrinology; 2013 May; 154(5):1701-10. PubMed ID: 23515289 [TBL] [Abstract][Full Text] [Related]
9. Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor. Gallagher EJ; Alikhani N; Tobin-Hess A; Blank J; Buffin NJ; Zelenko Z; Tennagels N; Werner U; LeRoith D Diabetes; 2013 Oct; 62(10):3553-60. PubMed ID: 23835331 [TBL] [Abstract][Full Text] [Related]
10. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437 [TBL] [Abstract][Full Text] [Related]
11. Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice. Ben-Shmuel S; Scheinman EJ; Rashed R; Orr ZS; Gallagher EJ; LeRoith D; Rostoker R J Endocrinol; 2015 Dec; 227(3):143-151. PubMed ID: 26383532 [TBL] [Abstract][Full Text] [Related]
12. Highly specific role of the insulin receptor in breast cancer progression. Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511 [TBL] [Abstract][Full Text] [Related]
13. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis. Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532 [TBL] [Abstract][Full Text] [Related]
14. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer. Simone BA; Dan T; Palagani A; Jin L; Han SY; Wright C; Savage JE; Gitman R; Lim MK; Palazzo J; Mehta MP; Simone NL Cell Cycle; 2016 Sep; 15(17):2265-74. PubMed ID: 27027731 [TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971 [TBL] [Abstract][Full Text] [Related]
16. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the WAP-Myc mouse mammary tumor model for spontaneous metastasis. Utz B; Turpin R; Lampe J; Pouwels J; Klefström J Sci Rep; 2020 Oct; 10(1):18733. PubMed ID: 33127915 [TBL] [Abstract][Full Text] [Related]
18. Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. Roy LD; Ghosh S; Pathangey LB; Tinder TL; Gruber HE; Mukherjee P BMC Cancer; 2011 Aug; 11():365. PubMed ID: 21859454 [TBL] [Abstract][Full Text] [Related]
19. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]